Oct 27, 2008 | 1
Drugs used to slow bone loss from osteoporosis increase the risk of life-threatening irregular heartbeats, according to new research that adds to previous warnings about the medicines.
Some 2.5 to 3 percent of people who took the drugs Fosomax and Reclast experienced an abnormal heart rhythm called atrial fibrillation, and 1 to 2 percent were hospitalized or died from the irregular heartbeats, according to an analysis of three studies involving more than 16,000 patients. The latter rate was as much as two times higher than the rate of serious, irregular heartbeats that occurred among patients taking placebos, said the study presented today in Philadelphia at the annual meeting of the American College of Chest Physicians. (The study abstract doesn't specify how many people taking the drugs died from atrial fibrillation.)
Oct 27, 2008 | 1
It’s hard to imagine an industry that isn’t affected by the global financial crisis, and science is no exception. The credit crunch will slow the development of new medicines, too, say economists and scientists meeting in London today and tomorrow.
The concern for novel treatments follows a boom time in the development of so-called “lifestyle drugs” to treat conditions such as impotence and baldness, which critics say has eclipsed innovation in treatments for serious diseases and those in developing countries where people cannot afford high-priced medicine. Investment in biotechs, companies that focus on developing new technologies from biology, last year hit a record-high $50 billion, but “the signs are that this has flattened,” says David Wield, director of the Economic and Social Research Council’s Innogen Center in Edinburgh.
Oct 22, 2008
The tumbling economy may be making Americans queasy, but they're apparently so worried about their pocketbooks that they're skipping their meds.
“I’ve seen patients today who said they stopped taking their Lipitor, their cholesterol-lowering medicine, because they can’t afford it,” James King, chairman of the American Academy of Family Physicians, tells the New York Times today. “I have patients who have stopped taking their osteoporosis medication.”
The number of prescriptions filled in the U.S. dropped for the first time in a decade, recent data from the tracking service IMS Health shows. Timothy Anderson of Sanford C. Bernstein & Company, a pharmaceutical analyst, told the Times the 2 percent dip is “most likely tied to a worsening economic environment.”
Deadline: Jan 27 2014
Reward: $15,000 USD
The Dow Chemical Company is the leading producer of polyalkylene glycols (PAGs) used in synthetic fluids and lubricants where petroleum,
Deadline: Jan 11 2014
Reward: $20,000 USD
Conventional washing machines cause excessive damage and wrinkling to clothes primarily during the water removal step. With the introduc
Give a 1 year subscription as low as $14.99X